Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion type Assertion NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_head.
- NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion description "[Overall, 62% of exons 1-7 PIK3CA mutants and 64% of exons 9-20 PIK3CA mutants were activating; 72% of exon 1-7 mutations have not previously been reported in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_provenance.
- NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion evidence source_evidence_literature NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_provenance.
- NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion SIO_000772 21266528 NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_provenance.
- NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion wasDerivedFrom befree-2016 NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_provenance.
- NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_assertion wasGeneratedBy ECO_0000203 NP867686.RA-hHFiYseA6TTzS_HwxxEmhqlD61SH6-5EqIrG9rB9nQ130_provenance.